Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Médecine et maladies infectieuses 2013-03, Vol.43 (3), p.134
Hauptverfasser: Bayonne Kombo, E S, Gathse, A
Format: Artikel
Sprache:fre
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue 3
container_start_page 134
container_title Médecine et maladies infectieuses
container_volume 43
creator Bayonne Kombo, E S
Gathse, A
description
doi_str_mv 10.1016/j.medmal.2013.01.008
format Article
fullrecord <record><control><sourceid>pubmed</sourceid><recordid>TN_cdi_pubmed_primary_23434355</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>23434355</sourcerecordid><originalsourceid>FETCH-LOGICAL-p108t-3745b42c9b50af1ae7d439b8fb8758d114f2c49eaa818fc26d465708faaa572f3</originalsourceid><addsrcrecordid>eNo9UEtLw0AYXASxtfoPRPaoh8RvX8nmKLXaQkGw1ZNQdpNvcUvzILsW8u8b8MEcBmZghhlCbhikDFj2sE9rrGpzSDkwkQJLAfQZmbI8K5IsK2BCLkPYA_DRhwsy4UKOUGpKPrfYtK49-p5-DR32AZvgoz_6ONDY0vjv3j29LTabexqGpurbGqlvqKEOx1aknYkemzhqDsuIFbUDXa4-rsi5M4eA1788I-_Pi-18maxfX1bzx3XSMdAxEblUVvKysAqMYwbzSorCamd1rnTFmHS8lAUao5l2Jc8qmakctDPGqJw7MSO3P7ndtx2P2HW9r00_7P5mihNwaFUv</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Bayonne Kombo, E S ; Gathse, A</creator><creatorcontrib>Bayonne Kombo, E S ; Gathse, A</creatorcontrib><identifier>EISSN: 1769-6690</identifier><identifier>DOI: 10.1016/j.medmal.2013.01.008</identifier><identifier>PMID: 23434355</identifier><language>fre</language><publisher>France</publisher><subject><![CDATA[Adenine - administration & dosage ; Adenine - adverse effects ; Adenine - analogs & derivatives ; Adenine - therapeutic use ; Adult ; Anti-HIV Agents - administration & dosage ; Anti-HIV Agents - adverse effects ; Anti-HIV Agents - therapeutic use ; Antiretroviral Therapy, Highly Active ; Asthenia - chemically induced ; Benzoxazines - administration & dosage ; Benzoxazines - therapeutic use ; Deoxycytidine - administration & dosage ; Deoxycytidine - analogs & derivatives ; Deoxycytidine - therapeutic use ; Dideoxynucleosides - administration & dosage ; Dideoxynucleosides - therapeutic use ; Drug Eruptions - etiology ; Drug Hypersensitivity - etiology ; Drug Substitution ; Emtricitabine ; Female ; Fever - chemically induced ; HIV Infections - complications ; HIV Infections - drug therapy ; Humans ; Lamivudine - administration & dosage ; Lamivudine - therapeutic use ; Nevirapine - administration & dosage ; Nevirapine - therapeutic use ; Organophosphonates - administration & dosage ; Organophosphonates - adverse effects ; Organophosphonates - therapeutic use ; Reverse Transcriptase Inhibitors - administration & dosage ; Reverse Transcriptase Inhibitors - adverse effects ; Reverse Transcriptase Inhibitors - therapeutic use ; Syndrome ; Tenofovir]]></subject><ispartof>Médecine et maladies infectieuses, 2013-03, Vol.43 (3), p.134</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23434355$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Bayonne Kombo, E S</creatorcontrib><creatorcontrib>Gathse, A</creatorcontrib><title>Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV</title><title>Médecine et maladies infectieuses</title><addtitle>Med Mal Infect</addtitle><subject>Adenine - administration &amp; dosage</subject><subject>Adenine - adverse effects</subject><subject>Adenine - analogs &amp; derivatives</subject><subject>Adenine - therapeutic use</subject><subject>Adult</subject><subject>Anti-HIV Agents - administration &amp; dosage</subject><subject>Anti-HIV Agents - adverse effects</subject><subject>Anti-HIV Agents - therapeutic use</subject><subject>Antiretroviral Therapy, Highly Active</subject><subject>Asthenia - chemically induced</subject><subject>Benzoxazines - administration &amp; dosage</subject><subject>Benzoxazines - therapeutic use</subject><subject>Deoxycytidine - administration &amp; dosage</subject><subject>Deoxycytidine - analogs &amp; derivatives</subject><subject>Deoxycytidine - therapeutic use</subject><subject>Dideoxynucleosides - administration &amp; dosage</subject><subject>Dideoxynucleosides - therapeutic use</subject><subject>Drug Eruptions - etiology</subject><subject>Drug Hypersensitivity - etiology</subject><subject>Drug Substitution</subject><subject>Emtricitabine</subject><subject>Female</subject><subject>Fever - chemically induced</subject><subject>HIV Infections - complications</subject><subject>HIV Infections - drug therapy</subject><subject>Humans</subject><subject>Lamivudine - administration &amp; dosage</subject><subject>Lamivudine - therapeutic use</subject><subject>Nevirapine - administration &amp; dosage</subject><subject>Nevirapine - therapeutic use</subject><subject>Organophosphonates - administration &amp; dosage</subject><subject>Organophosphonates - adverse effects</subject><subject>Organophosphonates - therapeutic use</subject><subject>Reverse Transcriptase Inhibitors - administration &amp; dosage</subject><subject>Reverse Transcriptase Inhibitors - adverse effects</subject><subject>Reverse Transcriptase Inhibitors - therapeutic use</subject><subject>Syndrome</subject><subject>Tenofovir</subject><issn>1769-6690</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9UEtLw0AYXASxtfoPRPaoh8RvX8nmKLXaQkGw1ZNQdpNvcUvzILsW8u8b8MEcBmZghhlCbhikDFj2sE9rrGpzSDkwkQJLAfQZmbI8K5IsK2BCLkPYA_DRhwsy4UKOUGpKPrfYtK49-p5-DR32AZvgoz_6ONDY0vjv3j29LTabexqGpurbGqlvqKEOx1aknYkemzhqDsuIFbUDXa4-rsi5M4eA1788I-_Pi-18maxfX1bzx3XSMdAxEblUVvKysAqMYwbzSorCamd1rnTFmHS8lAUao5l2Jc8qmakctDPGqJw7MSO3P7ndtx2P2HW9r00_7P5mihNwaFUv</recordid><startdate>201303</startdate><enddate>201303</enddate><creator>Bayonne Kombo, E S</creator><creator>Gathse, A</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>201303</creationdate><title>Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV</title><author>Bayonne Kombo, E S ; Gathse, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p108t-3745b42c9b50af1ae7d439b8fb8758d114f2c49eaa818fc26d465708faaa572f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>fre</language><creationdate>2013</creationdate><topic>Adenine - administration &amp; dosage</topic><topic>Adenine - adverse effects</topic><topic>Adenine - analogs &amp; derivatives</topic><topic>Adenine - therapeutic use</topic><topic>Adult</topic><topic>Anti-HIV Agents - administration &amp; dosage</topic><topic>Anti-HIV Agents - adverse effects</topic><topic>Anti-HIV Agents - therapeutic use</topic><topic>Antiretroviral Therapy, Highly Active</topic><topic>Asthenia - chemically induced</topic><topic>Benzoxazines - administration &amp; dosage</topic><topic>Benzoxazines - therapeutic use</topic><topic>Deoxycytidine - administration &amp; dosage</topic><topic>Deoxycytidine - analogs &amp; derivatives</topic><topic>Deoxycytidine - therapeutic use</topic><topic>Dideoxynucleosides - administration &amp; dosage</topic><topic>Dideoxynucleosides - therapeutic use</topic><topic>Drug Eruptions - etiology</topic><topic>Drug Hypersensitivity - etiology</topic><topic>Drug Substitution</topic><topic>Emtricitabine</topic><topic>Female</topic><topic>Fever - chemically induced</topic><topic>HIV Infections - complications</topic><topic>HIV Infections - drug therapy</topic><topic>Humans</topic><topic>Lamivudine - administration &amp; dosage</topic><topic>Lamivudine - therapeutic use</topic><topic>Nevirapine - administration &amp; dosage</topic><topic>Nevirapine - therapeutic use</topic><topic>Organophosphonates - administration &amp; dosage</topic><topic>Organophosphonates - adverse effects</topic><topic>Organophosphonates - therapeutic use</topic><topic>Reverse Transcriptase Inhibitors - administration &amp; dosage</topic><topic>Reverse Transcriptase Inhibitors - adverse effects</topic><topic>Reverse Transcriptase Inhibitors - therapeutic use</topic><topic>Syndrome</topic><topic>Tenofovir</topic><toplevel>online_resources</toplevel><creatorcontrib>Bayonne Kombo, E S</creatorcontrib><creatorcontrib>Gathse, A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Médecine et maladies infectieuses</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bayonne Kombo, E S</au><au>Gathse, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV</atitle><jtitle>Médecine et maladies infectieuses</jtitle><addtitle>Med Mal Infect</addtitle><date>2013-03</date><risdate>2013</risdate><volume>43</volume><issue>3</issue><spage>134</spage><pages>134-</pages><eissn>1769-6690</eissn><cop>France</cop><pmid>23434355</pmid><doi>10.1016/j.medmal.2013.01.008</doi></addata></record>
fulltext fulltext
identifier EISSN: 1769-6690
ispartof Médecine et maladies infectieuses, 2013-03, Vol.43 (3), p.134
issn 1769-6690
language fre
recordid cdi_pubmed_primary_23434355
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adenine - administration & dosage
Adenine - adverse effects
Adenine - analogs & derivatives
Adenine - therapeutic use
Adult
Anti-HIV Agents - administration & dosage
Anti-HIV Agents - adverse effects
Anti-HIV Agents - therapeutic use
Antiretroviral Therapy, Highly Active
Asthenia - chemically induced
Benzoxazines - administration & dosage
Benzoxazines - therapeutic use
Deoxycytidine - administration & dosage
Deoxycytidine - analogs & derivatives
Deoxycytidine - therapeutic use
Dideoxynucleosides - administration & dosage
Dideoxynucleosides - therapeutic use
Drug Eruptions - etiology
Drug Hypersensitivity - etiology
Drug Substitution
Emtricitabine
Female
Fever - chemically induced
HIV Infections - complications
HIV Infections - drug therapy
Humans
Lamivudine - administration & dosage
Lamivudine - therapeutic use
Nevirapine - administration & dosage
Nevirapine - therapeutic use
Organophosphonates - administration & dosage
Organophosphonates - adverse effects
Organophosphonates - therapeutic use
Reverse Transcriptase Inhibitors - administration & dosage
Reverse Transcriptase Inhibitors - adverse effects
Reverse Transcriptase Inhibitors - therapeutic use
Syndrome
Tenofovir
title Tenofovir hypersensitivity to tenofovir (DRESS) syndrome in a female patient infected by HIV
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T21%3A52%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Tenofovir%20hypersensitivity%20to%20tenofovir%20(DRESS)%20syndrome%20in%20a%20female%20patient%20infected%20by%20HIV&rft.jtitle=Me%CC%81decine%20et%20maladies%20infectieuses&rft.au=Bayonne%20Kombo,%20E%20S&rft.date=2013-03&rft.volume=43&rft.issue=3&rft.spage=134&rft.pages=134-&rft.eissn=1769-6690&rft_id=info:doi/10.1016/j.medmal.2013.01.008&rft_dat=%3Cpubmed%3E23434355%3C/pubmed%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/23434355&rfr_iscdi=true